4.5 Review

Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?

Related references

Note: Only part of the references are listed.
Review Infectious Diseases

Antibiotic exposure and adverse long-term health outcomes in children: A systematic review and meta-analysis

Quynh A. Duong et al.

Summary: This study systematically searched and analyzed observational studies, and found associations between antibiotic exposure and adverse long-term health outcomes in children. These outcomes include atopic dermatitis, allergic symptoms, food allergies, allergic rhinoconjunctivitis, wheezing, asthma, increased weight gain or overweight, obesity, juvenile idiopathic arthritis, psoriasis, autism spectrum disorders, and neurodevelopment disorders. The results suggest the need for careful antibiotic stewardship to avoid potential negative health outcomes.

JOURNAL OF INFECTION (2022)

Article Medicine, General & Internal

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Christopher J. L. Murray et al.

Summary: Antimicrobial resistance (AMR) poses a significant threat to global human health, and this study provides the most comprehensive estimates of AMR burden to date. By estimating deaths and disability-adjusted life-years (DALYs) associated with bacterial AMR in 204 countries and territories in 2019, the study highlights the impact of resistance and the leading pathogen-drug combinations contributing to it.

LANCET (2022)

Article Oncology

Cost-effectiveness of home-based care of febrile neutropenia in children with cancer

Michelle Tew et al.

Summary: The study found that home-based treatment of febrile neutropenia in low-risk patients is more cost-effective than in-hospital treatment, with savings arising from cheaper cost of caring for children at home. The home-based program is more effective and less costly compared to in-hospital care. The results are sensitive to the proportion of children eligible for home-based care.

PEDIATRIC BLOOD & CANCER (2022)

Review Pediatrics

Invasive fungal infections in neonates: a review

Kristin E. D. Weimer et al.

Summary: Invasive fungal infections, primarily caused by Candida and Aspergillus species, are the leading causes of morbidity and mortality in neonates. Proper identification and treatment, along with prevention strategies such as prophylactic antifungal therapy and reducing exposure to modifiable risk factors, are essential for managing these infections effectively.

PEDIATRIC RESEARCH (2022)

Article Microbiology

Long-term antibiotic exposure promotesmortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria

Rebecca A. Drummond et al.

Summary: Antibiotics increase susceptibility to invasive candidiasis by impairing antifungal immunity and increasing the risk of systemic bacterial co-infection. Vancomycin has a similar effect by reducing the frequency of Th17 cells in the gut. In humans, antibiotics are associated with an increased risk of invasive candidiasis and death.

CELL HOST & MICROBE (2022)

Article Oncology

Prediction of Bloodstream Infection in Pediatric Acute Leukemia by Microbiota and Volatile Organic Compounds Analysis

Mirjam E. van de Velde et al.

Summary: The potential of intestinal microbiota and fecal volatile organic compounds (VOCs) analyses in predicting bloodstream infections (BSIs) in pediatric leukemia patients was explored. Reduced microbial diversity and stability of Bacteroidetes were observed in patients who developed BSI. Pantoea was identified as a potential marker for BSI. Significant differences in fecal VOC profiles were measured between BSI cases and non-BSI controls.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2022)

Article Pediatrics

Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries

Naomi Ssenyonga et al.

Summary: The study examines global survival trends in leukemia among young patients aged 0-24 years, revealing significant variations in survival rates across different countries and regions. Children consistently have higher survival rates compared to adolescents and young adults.

LANCET CHILD & ADOLESCENT HEALTH (2022)

Article Medicine, General & Internal

Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures

Anne M. Butler et al.

Summary: This cohort study investigated the prevalence of non-guideline antibiotic prescribing for pediatric outpatient infections and its association with adverse drug events and higher healthcare expenditures. The study found that inappropriate antibiotic prescriptions were common and associated with increased risks of Clostridioides difficile infection and severe allergic reactions. Moreover, these prescriptions were also linked to higher healthcare expenditures. These findings underscore the individual and national consequences of inappropriate antibiotic prescribing and support the implementation of outpatient antibiotic stewardship programs.

JAMA NETWORK OPEN (2022)

Review Nutrition & Dietetics

Oral Administration of Probiotics Reduces Chemotherapy-Induced Diarrhea and Oral Mucositis: A Systematic Review and Meta-Analysis

Jing Feng et al.

Summary: This study conducted a systematic review and meta-analysis on the efficacy of oral probiotics in managing chemotherapy-induced adverse reactions. The results showed that oral probiotic use significantly decreased the risk of chemotherapy-induced diarrhea and oral mucositis. Interestingly, the beneficial effects of probiotics were found to be statistically significant only in Asian patients. Furthermore, the more species of bacteria they took, the lower the incidences of the adverse reactions occurred. However, more clinical trials are needed to further verify the efficacy of oral probiotic use against adverse reactions, and the species and number of probiotics should be optimized and standardized prior to clinical applications.

FRONTIERS IN NUTRITION (2022)

Article

Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again

Adrienne H. Long et al.

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting (2022)

Article Oncology

Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients

Gabrielle M. Haeusler et al.

Summary: This study aimed to describe the prevalence and clinical features of Clostridioides difficile infection (CDI) in pediatric patients receiving cancer treatments, propose a definition of severe CDI, and determine risk factors for CDI outcomes. The study found that the clinical cure rate was 82.9% and recurrence rate was 9.6%. Initial oral vancomycin was significantly associated with a reduction in repeated new CDI episodes.

EUROPEAN JOURNAL OF CANCER (2022)

Article Multidisciplinary Sciences

Time to antibiotics is unrelated to outcome in pediatric patients with fever in neutropenia presenting without severe disease during chemotherapy for cancer

Christa Koenig et al.

Summary: The time to antibiotics (TTA) was not associated with poor clinical outcomes in pediatric patients with fever in neutropenia (FN) without severe disease. However, in patients with severe disease, a longer TTA was trended towards more safety relevant events (SRE).

SCIENTIFIC REPORTS (2022)

Article Immunology

Blood transcriptomics identifies immune signatures indicative of infectious complications in childhood cancer patients with febrile neutropenia

Gabrielle M. Haeusler et al.

Summary: This study investigated the transcriptome of peripheral blood mononuclear cells (PBMCs) in children with cancer and febrile neutropenia (FN) to identify potential predictors of serious infection. The study found global differences in gene expression associated with specific immune responses in children with FN and documented infection, compared to episodes without documented infection. These differences may inform monitoring and aid in defining adequate treatment for different infectious aetiologies in children with cancer.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)

Review Dentistry, Oral Surgery & Medicine

Oral-Gut Microbiome Axis in the Pathogenesis of Cancer Treatment-Induced Oral Mucositis

Ghanyah Al-Qadami et al.

Summary: Oral mucositis is a common and debilitating complication of cancer treatments, causing pain and impairing oral functions, which can lead to treatment interruption and negative impacts on quality of life and tumor prognosis. Understanding the pathogenesis of OM helps identify new targets for intervention or prevention, with the oral-gut microbiome axis playing an important role in the development of OM.

FRONTIERS IN ORAL HEALTH (2022)

Article Pediatrics

PAnTher Cub: procalcitonin-guided antibiotic therapy for febrile neutropenia in children and young people with cancer-a single-arm pilot study

Jessica Elizabeth Morgan et al.

Summary: This pilot study aimed to evaluate the feasibility of using procalcitonin-guided stopping-rule for antibiotics in pediatric febrile neutropenia (FN) patients. The study found that this approach is feasible and interviews with professionals highlighted the importance of the research and provided suggestions for improvement.

BMJ PAEDIATRICS OPEN (2022)

Article Pediatrics

Early Discontinuation versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients with Febrile Neutropenia, Before Recovery of Counts: A Randomized Controlled Trial (DALFEN Study)

Akash Kumar et al.

Summary: Early discontinuation of antimicrobials in pediatric patients with low risk febrile neutropenia in an outpatient setting is as effective as continuing therapy before recovery of counts. This approach can lead to significant cost and resource benefits.

INDIAN JOURNAL OF PEDIATRICS (2021)

Article Oncology

Home-based care of low-risk febrile neutropenia in children-an implementation study in a tertiary paediatric hospital

Gabrielle M. Haeusler et al.

Summary: This study implemented a home-based management program for low-risk febrile neutropenia in children, demonstrating a significant reduction in hospital length of stay and healthcare resources saved. Ongoing evaluation will support sustainability and national scale-up of the program.

SUPPORTIVE CARE IN CANCER (2021)

Review Biochemistry & Molecular Biology

Microbiome-Derived Metabolites in Allogeneic Hematopoietic Stem Cell Transplantation

Riccardo Masetti et al.

Summary: The gut microbiome plays a significant role in hematopoietic stem cell transplantation, with its metabolites mediating interactions between intestinal microbial communities and the host. New data offer a fresh perspective on the role of microbiome-derived metabolites in transplant settings.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, General & Internal

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021

Benjamin W. Teh et al.

Summary: Antifungal prophylaxis is important in reducing morbidity and mortality from invasive fungal disease. Optimal and targeted use is crucial, especially with the emergence of new 'at-risk' groups and changing epidemiology. Monitoring local epidemiology and drug resistance is vital in guiding choices of prophylaxis and managing vulnerable patients effectively.

INTERNAL MEDICINE JOURNAL (2021)

Article Pharmacology & Pharmacy

Impact of severe oral mucositis in pediatric cancer patients on resource utilization and cancer treatment plans

Farah Alsheyyab et al.

Summary: This study conducted in a comprehensive cancer center in Amman, Jordan, evaluated the impact of severe mucositis on resource utilization and treatment plans in pediatric cancer patients. The results showed that severe oral mucositis is associated with significant resource utilization and requires modification of treatment protocols, such as dose reduction, delay, or discontinuation of chemotherapy. Further studies are needed to identify strategies to reduce the impact of mucositis in pediatric cancer patients.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2021)

Article Infectious Diseases

Antibiotic Resistant Bloodstream Infections in Pediatric Patients Receiving Chemotherapy or Hematopoietic Stem Cell Transplant: Factors Associated with Development of Resistance, Intensive Care Admission and Mortality

Elio Castagnola et al.

Summary: Bloodstream infections (BSI) caused by resistant Gram-negatives in children receiving antineoplastic chemotherapy or HSCT have high occurrence rates, with previous exposure to antibiotics or colonization of resistant pathogens being possible causes. Resistant Gram-negatives are significantly associated with ICU admission and mortality, with treating centers playing an important role in the outcome of treatment. The evidence of significant center-level variations on AR, ICU admission, and mortality emphasizes the need for careful local antibiotic stewardship and infection control programs.

ANTIBIOTICS-BASEL (2021)

Article Medicine, General & Internal

Association of a Safety Program for Improving Antibiotic Use With Antibiotic Use and Hospital-Onset Clostridioides difficile Infection Rates Among US Hospitals

Pranita D. Tamma et al.

Summary: The study found that the Agency for Healthcare Research and Quality Safety Program helped hospitals in establishing antibiotic stewardship programs (ASPs) and educating frontline clinicians to self-steward their antibiotic use. Antibiotic use decreased, and critical access hospitals, rural hospitals, and hospitals without infectious diseases specialists also benefited.

JAMA NETWORK OPEN (2021)

Review Health Care Sciences & Services

Fecal Microbiota Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review

Andrea Pession et al.

Summary: FMT has been used in allo-HSCT patients for therapeutic and preventive purposes, but further research on the biological mechanisms is needed. Concerns exist regarding the safety and efficacy of administering microbial consortia in immune-compromised patients.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Pediatrics

Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis

Coralie Raad et al.

Summary: This study investigated the incidence and microbiological spectrum of bloodstream infections in immunocompromised children treated at a tertiary referral center in France, finding that a step-down strategy for initial broad-spectrum antibiotic therapy at 48 hours can reduce the number of multi-drug resistant bacteria and decrease mortality related to bloodstream infections.

EUROPEAN JOURNAL OF PEDIATRICS (2021)

Review Infectious Diseases

Use of antibiotics is associated with worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis

Maria Tsikala-Vafea et al.

Summary: In cancer patients treated with ICIs, recent use of antibiotics is associated with worse clinical outcomes, including shorter overall survival, decreased response rate, and more disease progression. This negative association is stronger in patients with renal cell carcinoma or melanoma.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Oncology

8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation

Thomas Lehrnbecher et al.

Summary: The ECIL-8 Paediatric Group reviewed literature and formulated recommendations for antibiotic use in paediatric cancer patients and those undergoing haematopoietic cell transplantation, focusing on factors such as clinical stability and previous infection or colonization by resistant bacteria.

LANCET ONCOLOGY (2021)

Review Hematology

Gut microbiome in pediatric acute leukemia: from predisposition to cure

Riccardo Masetti et al.

Summary: The gut microbiome plays a crucial role in the development and progression of diseases, affecting treatment outcomes and complications in acute leukemia patients. Specific gut microbiome configurations may contribute to leukemogenesis, and alterations during therapy could lead to long-term health issues in survivors. This article reviews chronological changes in the gut microbiome of children with acute leukemia and highlights potential interventions to promote health.

BLOOD ADVANCES (2021)

Article Immunology

Next-Generation Sequencing to Detect Pathogens in Pediatric Febrile Neutropenia: A Single-Center Retrospective Study of 112 Cases

Kazuhiro Horiba et al.

Summary: This study used next-generation sequencing (NGS) to detect causative pathogens in patients with febrile neutropenia (FN). Results showed that NGS detected putative pathogens in some patients. Common bacteria from oral, skin, and gut flora were found in blood samples, suggesting microbiota translocation to the bloodstream.

OPEN FORUM INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Fatal Infections Among Cancer Patients: A Population-Based Study in the United States

Yongqiang Zheng et al.

Summary: Cancer patients are at a high risk of dying from fatal infections, with factors such as age, gender, race, cancer stage, and treatment influencing the mortality rates. Certain groups of cancer patients, such as those aged between 20-39 or >80 years, and those receiving chemotherapy, are particularly susceptible to fatal infections.

INFECTIOUS DISEASES AND THERAPY (2021)

Article Oncology

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

Amila K. Nanayakkara et al.

Summary: Antibiotic resistance poses a significant threat to the success of cancer therapy, necessitating measures to control its emergence. Establishing a specialized monitoring system and finding better ways to predict, prevent, and treat antibiotic-resistant infections will have a positive impact on the care of cancer patients.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Microbiology

Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation

Anna Cacilia Ingham et al.

Summary: The study found that bacterial diversity decreased in the gut, nose, and mouth during the first month post allo-HSCT, but reconstituted after 1-3 months. The microbial community composition underwent three phases over the course of a year. Specific taxa discriminated the microbiota temporally at all three body sites, including Enterococcus spp., Lactobacillus spp., and Blautia spp. in the gut. Pre-transplant microbial taxa were already altered compared to healthy children. Acute GvHD occurring after allo-HSCT could be predicted from microbiota composition pre-transplantation at all three body sites. Reconstitution of immune cells was associated with distinct taxa of the gut, oral, and nasal microbiota.

MICROBIOME (2021)

Article Medicine, Research & Experimental

Decontamination therapy in allo-HCT

Przemysaw Galazka et al.

Summary: The study in pediatric allo-HCT patients in Poland showed that gut colonization status and the use of antibiotics have an impact on the development of GI GVHD. Further research is needed to determine if the use of specific antibiotics reduces the risk of GVHD.

CURRENT RESEARCH IN TRANSLATIONAL MEDICINE (2021)

Article Hematology

Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host Disease

Caitlin W. Elgarten et al.

Summary: Carbapenems are associated with increased risk of acute graft-versus-host disease (aGVHD), especially with early exposure. Antipseudomonal penicillins show a trend towards increased risk, but with no statistical significance. There is no identified association between broad-spectrum cephalosporins and aGVHD. Further research is necessary to clarify the underlying mechanism of this association.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

Article Medicine, General & Internal

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

Jonathan U. Peled et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Hematology

Baseline Gut Microbiota Composition Is Associated with Major Infections Early after Hematopoietic Cell Transplantation

Hemant S. Murthy et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

Review Dermatology

Breakthrough invasive fungal infections: Who is at risk?

Jeffrey D. Jenks et al.

MYCOSES (2020)

Article Medicine, General & Internal

Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia

Gabrielle M. Haeusler et al.

ECLINICALMEDICINE (2020)

Article Infectious Diseases

Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin-Tazobactam or Cefepime: A Cohort Study

Kathryn M. Cook et al.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2019)

Article Infectious Diseases

US Emergency Department Visits for Adverse Drug Events From Antibiotics in Children, 2011-2015

Maribeth C. Lovegrove et al.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2019)

Review Public, Environmental & Occupational Health

Risk factors for Clostridium difficile infection in pediatric inpatients: A meta-analysis and systematic review

Scott Anjewierden et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2019)

Article Medicine, General & Internal

Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

Zachariah DeFilipp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Multidisciplinary Sciences

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

Bertrand Routy et al.

SCIENCE (2018)

Article Cell Biology

Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy

Alfredo Perales-Puchalt et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2018)

Article Pediatrics

Measuring the financial and productivity burden of paediatric hospitalisation on the wider family network

Virginia Mumford et al.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2018)

Article Pediatrics

Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice

Gabrielle M. Haeusler et al.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2018)

Article Hematology

Antibiotic Exposure and Reduced Short Chain Fatty Acid Production after Hematopoietic Stem Cell Transplant

Lindsey E. Romick-Rosendale et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)

Review Microbiology

Anticancer effects of the microbiome and its products

Laurence Zitvogel et al.

NATURE REVIEWS MICROBIOLOGY (2017)

Article Oncology

Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study

Gabrielle M. Haeusler et al.

BRITISH JOURNAL OF CANCER (2017)

Article Oncology

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

J. Klastersky et al.

ANNALS OF ONCOLOGY (2016)

Letter Pediatrics

Variation in practice remains in the UK management of paediatric febrile neutropenia

Fiona Herd et al.

ARCHIVES OF DISEASE IN CHILDHOOD (2016)

Review Infectious Diseases

Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis

Konstantinos Z. Vardakas et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)

Review Oncology

Systematic review of reduced therapy regimens for children with low risk febrile neutropenia

Jessica E. Morgan et al.

SUPPORTIVE CARE IN CANCER (2016)

Article Genetics & Heredity

Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection

Emmanuel Montassier et al.

GENOME MEDICINE (2016)

Article Medicine, General & Internal

Clostridium difficile infection

Wiep Klaas Smits et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Letter Pediatrics

What are the risk factors for antibiotic resistant Gram-negative bacteraemia in children with cancer?

Gabrielle M. Haeusler et al.

ARCHIVES OF DISEASE IN CHILDHOOD (2015)

Review Multidisciplinary Sciences

Cancer and the microbiota

Wendy S. Garrett

SCIENCE (2015)

Review Infectious Diseases

Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis

Claudia Slimings et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)

Article Dermatology

Invasive fungal infections in paediatric acute myeloid leukaemia

D. L. Johnston et al.

MYCOSES (2013)

Article Multidisciplinary Sciences

The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

Sophie Viaud et al.

SCIENCE (2013)

Article Immunology

Risk Factors and Outcomes Associated With Severe Clostridium difficile Infection in Children

Jason Kim et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)

Article Immunology

Results From a Prospective, International, Epidemiologic Study of Invasive Candidiasis in Children and Neonates

William J. Steinbach et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)

Article Immunology

CLOSTRIDIUM DIFFICILE INFECTION AMONG CHILDREN WITH CANCER

Eric Tai et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)

Article Infectious Diseases

Fever and neutropenia: the early years

Gerald P. Bodey

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)

Article Oncology

The Clinical Feature of Invasive Fungal Infection in Pediatric Patients With Hematologic and Malignant Diseases

Ryoji Kobayashi et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2008)

Article Pediatrics

Adverse drug reactions among children over a 10-year period

Jennifer Le et al.

PEDIATRICS (2006)

Review Microbiology

Clostridium difficile toxins:: Mechanism of action and role in disease

DE Voth et al.

CLINICAL MICROBIOLOGY REVIEWS (2005)

Article Immunology

Candidal meningitis in children with cancer

JA McCullers et al.

CLINICAL INFECTIOUS DISEASES (2000)